1 year return (CAGR)
-24.58%
Kyverna Therapeutics, Inc. Common Stock Exchange (NASDAQ, USD)
KYTX
5.89
+0.26 (+4.62%)
HealthcareBiotechnology
Loading...
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Adobe 2026 Q3 – Is sentiment driving the price?
Read MoreMarketcap
364.26M
Price/Sales
-
Ent value
386.73M
Price/Book
2.20
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
-
Stock information
What is a stock exchange? Operation, actors, examples
Read MoreStock chart
Loading...
Stock price data
| Open | 5.58 |
| Daily high | 5.93 |
| Daily low | 5.56 |
| Daily Volume | 995K |
| All-time high | 30.10 |
| 1y analyst estimate | 30.40 |
| Beta | 1.99 |
| EPS (TTM) | -2.51 |
| Dividend per share | 0.00 |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| KYTX | S&P500 | |
| Current price drop from All-time high | -80.43% | -0.87% |
| Highest price drop | -93.92% | -56.47% |
| Date of highest drop | 16 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -73.33% | -10.65% |
| Avg time to new high | 342 days | 12 days |
| Max time to new high | 682 days | 1805 days |
News
